Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. (RETA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RETA · as of Jun 9, 2026
Key Statistics
Explore Reata Pharmaceuticals, Inc. Data
reta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 40.0%
The RETA analyst consensus is Hold, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $62.67, representing -63.64% downside from the current price of $172.36.
Competitors & Peers
reta competitorsRETA
ABCM
ALPN
BPMC
CERE
IMGNStock Performance
Full HistoryAbout Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for individuals afflicted with severe or life-t…
what is reata pharmaceuticals, inc. · reta stock overview · reata pharmaceuticals, inc. company profile · who is reata pharmaceuticals, inc. ceo · reta NASDAQ · reata pharmaceuticals, inc. headquarters · reata pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Reata Pharmaceuticals, Inc. (RETA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 26, 2016. As of the latest trading session, RETA stock price is $172.36, with a market capitalization of $6.6B. The stock has returned +424.85% over the past 12 months and +369.52% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Reata Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $62.67. In fiscal year 2022, Reata Pharmaceuticals, Inc. reported revenue of $2.2M and net income of -$311.9M. For detailed data — including Reata Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Reata Pharmaceuticals, Inc. (RETA) stock price is $172.36. The stock is traded on NASDAQ under the ticker symbol RETA. The 52-week range is $21.83 – $172.46.